top of page

Magic Mushrooms: The Surprising New Hope for Treating Anorexia!

Anorexia nervosa is a devastating mental health disorder marked by an intense fear of weight gain and a distorted body image. Individuals with anorexia often engage in severely restrictive eating habits, leading to dangerous levels of malnutrition. Despite its severity, effective treatments remain elusive, with psychotherapy showing limited success and no approved drug treatments available. The search for new solutions has led researchers to investigate an unlikely candidate: psilocybin, the active compound in magic mushrooms.

Psilocybin is a psychedelic substance that has shown potential in treating various mental health conditions. It produces profound changes in perception, mood, and cognition, which can help disrupt the rigid thinking patterns often seen in anorexia patients. However, despite its promise, psilocybin is not yet ready for clinical use in treating anorexia; more research is needed to confirm its safety and effectiveness.

The treatment protocol for psilocybin involves administering the drug in a controlled, clinical setting. Patients undergo preparation therapy before the dosing session to help them understand what to expect. The actual dosing takes place in a safe environment, with medical professionals on hand to monitor the experience. Following the session, patients participate in integration therapy to process their experiences and incorporate any insights gained into their daily lives.

Psilocybin's psychedelic effects can lead to altered thinking, a changed sense of time and emotions, and, in some cases, hallucinations. These effects can help patients break free from their entrenched, negative thought patterns. Importantly, psilocybin treatment is combined with structured psychotherapy to help patients make sense of their experiences and foster lasting change.

Initial research into psilocybin-assisted psychotherapy has shown promising results, particularly in treating depression. Studies have found that psilocybin can increase cognitive flexibility—the ability to adapt thinking in response to changing circumstances. This characteristic is believed to be beneficial for conditions like depression and alcohol use disorder, where rigid thinking is common.

Given the similar cognitive rigidity seen in anorexia, researchers have begun to explore psilocybin's potential in this area. A small pilot study published in Nature Medicine in 2023 involved ten women with anorexia. The study found that psilocybin-assisted therapy (with a 25mg dose) was safe and well-tolerated, with no significant side effects reported. Notably, 40% of participants experienced significant reductions in their eating disorder behaviors. However, the study’s scope was limited, with only one dosing session and no long-term follow-up.

Recent animal studies have provided additional insights. For example, research on rats showed that psilocybin could improve cognitive flexibility and lead to weight gain. These changes were linked to the serotonin neurotransmitter system, which regulates mood, behavior, and satiety. Given that individuals with anorexia often have disturbances in their serotonin systems, psilocybin's potential to modulate these pathways is particularly relevant.

While the initial findings are promising, much more research is needed before psilocybin can be considered a viable treatment for anorexia. Ongoing clinical trials are crucial to understanding the drug’s efficacy and safety. Research teams at the University of Sydney and Swinburne University are conducting trials to explore optimal dosing and patient responses.

Swinburne's study, for instance, involves an initial low dose of 5mg, followed by two higher doses of 25mg spaced several weeks apart. This phased approach aims to help participants acclimate to the psychedelic experience and minimize potential negative effects.

It's important to recognize that psilocybin treatment may not be suitable for everyone. Some individuals may experience adverse reactions or find that their mental health deteriorates. Identifying which patients are most likely to benefit, and under what conditions, is a key focus of ongoing research.

Psilocybin-assisted psychotherapy represents a potential breakthrough in the treatment of anorexia nervosa, offering hope where traditional therapies have failed. While we are still some way from seeing this treatment in mainstream clinical practice, the ongoing research is a critical step towards understanding how psychedelics could revolutionize mental health care.

Do you think psychedelics like psilocybin could revolutionize treatment for severe mental health disorders like anorexia?

  • Yes, they have great potential.

  • Maybe, but more research is needed.

  • No, it's too experimental.

  • I'm not sure, I need more information.


News (2).png
News (4).png
Check back soon
Once posts are published, you’ll see them here.
bottom of page